Heba Ijaz

Publications by Year

Research Areas

Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics, Cancer therapeutics and mechanisms, Epigenetics and DNA Methylation

Most-Cited Works

• → The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science(2022)85 cited
• → Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)(2019)65 cited
• → Pediatric high-grade glioma resources from the Children’s Brain Tumor Tissue Consortium(2019)42 cited
• → SIRT1 activates the expression of fetal hemoglobin genes(2017)41 cited
• → Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma(2023)29 cited
• → Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants(2022)20 cited
• → The Children’s Brain Tumor Network (CBTN) - Accelerating Research in Pediatric Central Nervous System Tumors through Collaboration and Open Science(2022)8 cited
• → PDTM-16. PEDIATRIC HIGH GRADE GLIOMA RESOURCES FROM THE CHILDREN’S BRAIN TUMOR TISSUE CONSORTIUM (CBTTC) AND PEDIATRIC BRAIN TUMOR ATLAS (PBTA)(2019)5 cited
• → Pediatric High Grade Glioma Resources From the Children’s Brain Tumor Tissue Consortium (CBTTC) and Pediatric Brain Tumor Atlas (PBTA)(2019)4 cited
• → Abstract CT029: Pediatric phase 2 trial of the WEE1 inhibitor adavosertib (AZD1775) and irinotecan: A Children's Oncology Group Study (ADVL1312)(2021)1 cited